Preventing fungal contamination in pharmaceuticals
European Pharmaceutical Review
MARCH 11, 2024
In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. According to the authors, these were linked to 55 fatal cases of fungal meningitis.
77 
Let's personalize your content